Replies to post #299777 on Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

And yet: when Wile E Coyote falls all the way to the canyon floor is he hurt? Not at all. He bounces up and resumes business as usual.

So it will be for us shareholders: the share price will plunge, obviously, but we will still be on track for UC trials, whenever those may finally start.

UC lottery tickets will be much cheaper, sadly, than the current buy in- let's guess 5 cents, 7 cents, whatever. But surely half or less than today's prices.

Let's regroup on the canyon floor and start the UC trail- a very slow one, rocky, difficult, bt that is our only way forward.

Day 3 Wile E. Coyote!

[To infinity and beyond!]

Some shareholders will not catch on to B for c play failure for quite a while, unable to see it or believe it. Perhaps they did not live through the ugly Prurisol debacle- the way that shareholders were left in the dark.

Plenty of darkness too in the B OM trial. The bogus subset data release on a couple of occasions a year ago, as the company sensed the data were not up to snuff.

NO deal- that's what counts of course, as opposed to not a failure. Mucositis patients did not get a drug from Innov Pharm to help them because the results failed to bring the swarm of big Pharma that would have come for better results. Too bad for all- silly to pretend it's a win, when it's clearly a loss.

Perhaps part of the same coin- the inability to see when an opportunity is gone, and done.

Oh- but there will be BIG very BIG buying opps as the share price plunges

[Stan Dango]

Liquidated the rest of my holdings.

Have had shares for several years with a few buys and sells especially with the covid seesaw we’ve been on.

Had a lot of emotional attachment to this stock and after profiting off the last PR made the mistake to rebuy once it hit .20 with the classic FOMO.

But, if you look at Infinity and a previous poster’s list of the PR’s since the B-covid saga began, you can clearly tell that B did not pass muster at the RBL - It’s been months now and there would be press releases about the Positive data and surely a partner, a buyout, or at least human trials going. The last few press releases end with Leo asking potential partners on studying B to email him. That’s the tell. If this drug was effective it would already be far into advanced testing stages and Leo wouldn’t need to beg for help.

We were promised data on B in human lung cells a long time ago and all we were given is some kidney data.

Will there be another PR soon from Leo that might pump the stock? Absolutely - probably this week. But I’ve had enough.

GLTA